Ionis Pharmaceuticals Stock (NASDAQ: IONS) stock price, news, charts, stock research, profile.
Open | $44.950 |
Close | - |
Volume / Avg. | 78.936K / 1.190M |
Day Range | 44.345 - 44.950 |
52 Wk Range | 33.320 - 54.445 |
Market Cap | $6.467B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 7.34% |
Days to Cover | 8.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ionis Pharmaceuticals (NASDAQ: IONS) through any online brokerage.
Other companies in Ionis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Ionis Pharmaceuticals (NASDAQ: IONS) was reported by Oppenheimer on Wednesday, March 6, 2024. The analyst firm set a price target for 72.00 expecting IONS to rise to within 12 months (a possible 61.22% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $44.66 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ionis Pharmaceuticals.
Ionis Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Ionis Pharmaceuticals.
Ionis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.